placebo + varenicline tartrate + bupropion hydrochloride + Nicotine Replacement Therapy Patch
ApprovedCompleted 0 views this week 0 watching⚡ Active
Interest: 43/100
43
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Smoking Cessation
Conditions
Smoking Cessation
Trial Timeline
May 1, 2012 → Jul 1, 2015
NCT ID
NCT01574703About placebo + varenicline tartrate + bupropion hydrochloride + Nicotine Replacement Therapy Patch
placebo + varenicline tartrate + bupropion hydrochloride + Nicotine Replacement Therapy Patch is a approved stage product being developed by Pfizer for Smoking Cessation. The current trial status is completed. This product is registered under clinical trial identifier NCT01574703. Target conditions include Smoking Cessation.
What happened to similar drugs?
12 of 20 similar drugs in Smoking Cessation were approved
Approved (12) Terminated (0) Active (8)
Hype Score Breakdown
Clinical
20
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01574703 | Approved | Completed |
| NCT01456936 | Approved | Completed |
Competing Products
20 competing products in Smoking Cessation